Denali Therapeutics
Overview
Denali Therapeutics is a biopharmaceutical company focused on developing innovative treatments for neurodegenerative diseases through advanced drug discovery and neurobiological research. The company leverages cutting-edge technologies and scientific insights to create therapeutic solutions targeting the underlying mechanisms of neurological disorders.
More in Neurotechnology
Latest industry news
China's Neurotech Ambitions Signal a New Frontier in the Global Brain Race
2026-10-18 · Industry
Functional Ultrasound BCIs Cross a Threshold: From Brain Reading to Two-Way Control
2026-10-17 · Research
Visual Cues Are Quietly Skewing BCI Accuracy Scores, and the Field Is Taking Notice
2026-10-16 · Research
ReVision Implant Secures €4 Million to Advance Neural Vision Restoration Technology
2026-10-15 · Funding
Company details
Category
🏢 Neurotechnology
Funding
Private
Listed
2026-07-29
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →